136 related articles for article (PubMed ID: 12630328)
21. Kinetics of anti-mannan antibodies useful in confirming invasive candidiasis in immunocompromised patients.
van Deventer AJ; Goessens WH; van Zeijl JH; Mouton JW; Michel MF; Verbrugh HA
Microbiol Immunol; 1996; 40(2):125-31. PubMed ID: 8867608
[TBL] [Abstract][Full Text] [Related]
22. [Candida albicans infection in patients with oral squamous cell carcinoma].
Canković M; Bokor-Bratić M
Vojnosanit Pregl; 2010 Sep; 67(9):766-70. PubMed ID: 20954415
[TBL] [Abstract][Full Text] [Related]
23. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.
Zaragoza R; Pemán J; Quindós G; Iruretagoyena JR; Cuétara MS; Ramírez P; Gómez MD; Camarena JJ; Viudes A; Pontón J;
Clin Vaccine Immunol; 2009 Oct; 16(10):1527-8. PubMed ID: 19675223
[TBL] [Abstract][Full Text] [Related]
24. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
25. Anti-Candida antibodies in serum and saliva of patients with denture stomatitis.
Kantardjiev TV; Popova EV
Folia Med (Plovdiv); 2002; 44(4):39-44. PubMed ID: 12751686
[TBL] [Abstract][Full Text] [Related]
26. Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.
Jouault T; Delaunoy C; Sendid B; Ajana F; Poulain D
Clin Diagn Lab Immunol; 1997 May; 4(3):328-33. PubMed ID: 9144372
[TBL] [Abstract][Full Text] [Related]
27. Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria.
Ergon MC; iĺknur T; Yućesoy M; Oźkan S
Clin Exp Dermatol; 2007 Nov; 32(6):740-3. PubMed ID: 17953642
[TBL] [Abstract][Full Text] [Related]
28. Detection of Candida albicans ADH1 and ADH2 mRNAs in human archival oral biopsy samples.
Bakri MM; Cannon RD; Holmes AR; Rich AM
J Oral Pathol Med; 2014 Oct; 43(9):704-10. PubMed ID: 24931506
[TBL] [Abstract][Full Text] [Related]
29. Candiduria in non-neutropenic critically-ill surgical patients. Detection of IgA, IgG and IgM antibodies to Candida albicans by germ tube immunofluorescence.
Torres-Rodríguez JM; Madrenys-Brunet N; Nolla-Salas J; Carceller A; Tur C
Mycoses; 1997 Dec; 40(11-12):439-44. PubMed ID: 9470409
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
Ibrahim el-SM; Rahman AK; Isoda R; Umeda K; Van Sa N; Kodama Y
Vaccine; 2008 Apr; 26(17):2073-80. PubMed ID: 18375022
[TBL] [Abstract][Full Text] [Related]
31. [Candida albicans serum precipitins among blood donors: striking serological and cultural findings of Candida albicans in alcoholics (author's transl)].
Staib F; Focking M; Fröhlich B; Blisse A
Mykosen; 1977 Nov; 20(11):423-30. PubMed ID: 339079
[No Abstract] [Full Text] [Related]
32. Immunodiagnosis in oral candidiasis. A review.
Jeganathan S; Chan YC
Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):451-4. PubMed ID: 1408018
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-linked immunosorbent assay measurement of fluctuations in antibody titer and antigenemia in cancer patients with and without candidiasis.
Fujita S; Matsubara F; Matsuda T
J Clin Microbiol; 1986 Mar; 23(3):568-75. PubMed ID: 3082925
[TBL] [Abstract][Full Text] [Related]
34. Effect of antigen used in the detection of anti-Candida albicans antibodies.
Garcia-de-Lomas J; Nogueira JM; Buesa FJ; Prat J; Mir A; Moreno F; Gea A
Mycopathologia; 1985 Oct; 92(1):23-9. PubMed ID: 3906404
[TBL] [Abstract][Full Text] [Related]
35. Humoral response to blastospores and mycelium in mice injected with different doses of Candida albicans.
Mesón OE; Valdez JC; de Alderete NG; Sirena A; Perdigón G
Rev Latinoam Microbiol; 1992; 34(2):101-6. PubMed ID: 1345309
[TBL] [Abstract][Full Text] [Related]
36. [Correlations between culture findings of Candida albicans in the digestive tract and the antibody titers of indirect Candida immunofluorescence].
Kühn G
Mykosen; 1985 Jul; 28(7):342-54. PubMed ID: 3897856
[No Abstract] [Full Text] [Related]
37. Evaluation of the Protective Role for Candida albicans-reactive Immunoglobulin A against Oral Fungal Infection.
Wulandari EAT; Saraswati H; Adawiyah R; Djauzi S; Wahyuningsih R; Lee S; Price P
J Acquir Immune Defic Syndr; 2018 May; 78(1):e4-e6. PubMed ID: 29465626
[No Abstract] [Full Text] [Related]
38. The ultrastructure of Candida albicans infections.
Marrie TJ; Costerton JW
Can J Microbiol; 1981 Nov; 27(11):1156-64. PubMed ID: 6172189
[TBL] [Abstract][Full Text] [Related]
39. [Killer toxin and enzyme production by Candida albicans isolated from buccal mucosa in patients with cancer].
de Oliveira EE; Silva SC; Soares AJ; Attux C; Cruvinel B; Silva Mdo R
Rev Soc Bras Med Trop; 1998; 31(6):523-7. PubMed ID: 9859695
[TBL] [Abstract][Full Text] [Related]
40. Oral candidiasis: effects of antifungal therapy upon clinical signs and symptoms, salivary antibody, and mucosal adherence of Candida albicans.
Epstein JB; Pearsall NN; Truelove EL
Oral Surg Oral Med Oral Pathol; 1981 Jan; 51(1):32-6. PubMed ID: 7007953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
